AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7696887 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-alpha-hydroxy-calciferol (1 microgram daily)
Number of subjects: 88
Study 7696887 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inactive drug)
Number of subjects: 88
Study 3229387 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-volume group (LVG) injected with up to 30 ml per session
Number of subjects: 39
Study 3229387 — intervention group
Group type: COMPARATOR
Intervention: Small-volume group (SVG) injected with up to 15 ml per session
Number of subjects: 39
Study 3229387 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-volume group (LVG)
Number of subjects: 39
Study 3229387 — intervention group
Group type: COMPARATOR
Intervention: Small-volume group (SVG)
Number of subjects: 39
Study 28378199 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard dissemination (mailed materials)
Number of subjects: 254
Study 28378199 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced dissemination (mailed materials plus follow-up call)
Number of subjects: 254
Study 28378199 — intervention group
Group type: EXPERIMENTAL
Intervention: Charla (face-to-face group discussion)
Number of subjects: 254
Study 27515872 — intervention group
Group type: EXPERIMENTAL
Intervention: Withania somnifera extract (120 mg/day), n = 15
Number of subjects: 30
Study 27515872 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n = 15
Number of subjects: 30
Study 24974901 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml levobupivacaine 0.5%
Number of subjects: 51
Study 24974901 — intervention group
Group type: COMPARATOR
Intervention: 20 ml saline 0.9% (control group)
Number of subjects: 51
Study 22490197 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound whole grain and health education
Number of subjects: 418
Study 22490197 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 418
Study 20537611 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (n = 19)
Number of subjects: 31
Study 20537611 — intervention group
Group type: COMPARATOR
Intervention: No treatment (n = 12)
Number of subjects: 31
Study 18946563 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 75
Study 18946563 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 75
Study 18946563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 15080859 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 0
Study 15080859 — intervention group
Group type: COMPARATOR
Intervention: Control (no amphetamine)
Number of subjects: 0
Study 12224053 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Number of subjects: 5
Study 12224053 — intervention group
Group type: COMPARATOR
Intervention: Control (no electrical stimulation)
Number of subjects: 5
Study 9577947 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive baroreflex sensitivity tests (alpha-index and sequence analysis)
Number of subjects: 52
Study 9577947 — intervention group
Group type: COMPARATOR
Intervention: Phenylephrine method
Number of subjects: 52
Study 7664702 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 0.6 mg/kg
Number of subjects: 90
Study 7664702 — intervention group
Group type: COMPARATOR
Intervention: Midazolam 0.06 mg/kg
Number of subjects: 90
Study 2539829 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 fatty acids
Number of subjects: 0
Study 637999 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane anaesthesia with FIO2 values of 0.33, 0.5, and 0.75
Number of subjects: 20
Study 637999 — intervention group
Group type: EXPERIMENTAL
Intervention: Trichloroethylene anaesthesia with FIO2 values of 0.33, 0.5, and 0.75
Number of subjects: 20
Study 31455099 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported emotional eating using the DEBQ
Number of subjects: 0
Study 31455099 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported emotional eating using the EES (original and revised versions)
Number of subjects: 0
Study 31455099 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 0
Study 31455099 — intervention group
Group type: COMPARATOR
Intervention: Negative mood induction
Number of subjects: 0
Study 31011263 — intervention group
Group type: EXPERIMENTAL
Intervention: Mother's knowledge on optimal complementary feeding (AOR=5.4, 95%CI: 2.7, 11)
Number of subjects: 0
Study 31011263 — intervention group
Group type: EXPERIMENTAL
Intervention: Postnatal care service utilization (AOR=3.4, 95%CI: 1.7, 7)
Number of subjects: 0
Study 31011263 — intervention group
Group type: EXPERIMENTAL
Intervention: Household food security (AOR=5, 95%CI: 2.5, 10.5)
Number of subjects: 0
Study 31011263 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal complementary feeding practices
Number of subjects: 0
Study 28506854 — intervention group
Group type: COMPARATOR
Intervention: Solifenacin oral suspension
Number of subjects: 148
Study 26089677 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved blood pressure goal SBP ≤125 mmHg
Number of subjects: 166
Study 26089677 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved blood pressure goal SBP ≤140 mmHg
Number of subjects: 166
Study 26089677 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieved blood pressure goal SBP ≤160 mmHg
Number of subjects: 166
Study 26089677 — intervention group
Group type: EXPERIMENTAL
Intervention: SBP reduction of ≥10 mmHg
Number of subjects: 166
Study 26089677 — intervention group
Group type: EXPERIMENTAL
Intervention: DBP reduction of ≥5 mmHg
Number of subjects: 166
Study 26089677 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive test performances associated with blood pressure goals
Number of subjects: 166
Study 26089677 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnoses of MCI or dementia associated with blood pressure goals
Number of subjects: 166
Study 22696494 — intervention group
Group type: EXPERIMENTAL
Intervention: LA fractional change
Number of subjects: 199
Study 22696494 — intervention group
Group type: COMPARATOR
Intervention: LAmax, LAmin, LA passive fraction
Number of subjects: 199
Study 21804501 — intervention group
Group type: EXPERIMENTAL
Intervention: S. boulardii 250 mg twice daily orally for one month
Number of subjects: 70
Study 21804501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 19370040 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 195
Study 16720672 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance for epidural catheter placement
Number of subjects: 64
Study 16720672 — intervention group
Group type: COMPARATOR
Intervention: Loss-of-resistance (LOR) technique for epidural catheter placement
Number of subjects: 64
Study 15142153 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 293
Study 15142153 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine
Number of subjects: 293
Study 15142153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study 11294478 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term lithium treatment (>6 months)
Number of subjects: 52
Study 11294478 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term lithium treatment (<6 months)
Number of subjects: 52
Study 11294478 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy males)
Number of subjects: 52
Study 9597415 — intervention group
Group type: EXPERIMENTAL
Intervention: Congenital heart disease adults
Number of subjects: 166
Study 3620755 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency emphasis hearing aid
Number of subjects: 0
Study 3620755 — intervention group
Group type: COMPARATOR
Intervention: Conventional, flatter response aid
Number of subjects: 0
Study 29684148 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 75 mg
Number of subjects: 69
Study 29684148 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 200 mg
Number of subjects: 69
Study 29684148 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 500 mg
Number of subjects: 69
Study 29684148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 29684148 — intervention group
Group type: EXPERIMENTAL
Intervention: JNJ‐53718678 (all doses)
Number of subjects: 69
Study 27543643 — intervention group
Group type: EXPERIMENTAL
Intervention: Fermented milk containing multiple probiotic strains and prebiotic fiber
Number of subjects: 120
Study 27543643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 24705147 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil/leucovorin (5-FU/LV)
Number of subjects: 60
Study 24705147 — intervention group
Group type: EXPERIMENTAL
Intervention: capecitabine (CA)
Number of subjects: 60
Study 22573470 — intervention group
Group type: EXPERIMENTAL
Intervention: ENABLE II concurrent oncology palliative care intervention
Number of subjects: 72
Study 22573470 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial participation
Number of subjects: 72
Study 21914041 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubiprostone (48 μg day(-1) for 14 days)
Number of subjects: 62
Study 21914041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 21914041 — intervention group
Group type: EXPERIMENTAL
Intervention: Lubiprostone
Number of subjects: 62
Study 18675844 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education program (dietary advice during the first year based on Brazilian national health policy and WHO guidelines)
Number of subjects: 397
Study 18675844 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education program
Number of subjects: 397
Study 17023239 — intervention group
Group type: COMPARATOR
Intervention: Heat wrap (prevention study, n=17)
Number of subjects: 67
Study 17023239 — intervention group
Group type: COMPARATOR
Intervention: Heat wrap (treatment study, n=16)
Number of subjects: 67
Study 14605043 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 micro g/d
Number of subjects: 81
Study 14605043 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 11183431 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy (essential oils: vetivert, bergamot, and geranium)
Number of subjects: 66
Study 11183431 — intervention group
Group type: COMPARATOR
Intervention: Placebo (hair conditioner)
Number of subjects: 66
Study 8981288 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid Replacement Trial (FR-trial) with water bolus of 3.0 ml kg‐1 body mass pre-exercise and 2.0 ml kg‐1 body mass every 15 min during exercise
Number of subjects: 8
Study 8981288 — intervention group
Group type: COMPARATOR
Intervention: No Fluid Ingestion Trial (NF-trial) with no fluid ingested
Number of subjects: 8
Study 1361309 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 10 micrograms/kg
Number of subjects: 60
Study 1361309 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 15 micrograms/kg
Number of subjects: 60
Study 1361309 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 50 micrograms/kg
Number of subjects: 60
Study 1361309 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 75 micrograms/kg
Number of subjects: 60
Study 3026273 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 4.8 mg
Number of subjects: 6
Study 3026273 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 16 mg
Number of subjects: 6
Study 3026273 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31876202 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental tasking during rotary chair testing (RCT)
Number of subjects: 17
Study 31876202 — intervention group
Group type: COMPARATOR
Intervention: No mental task during rotary chair testing (RCT)
Number of subjects: 17
Study 29524029 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) palatal bandage
Number of subjects: 24
Study 29524029 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PRF bandage)
Number of subjects: 24
Study 26995802 — intervention group
Group type: EXPERIMENTAL
Intervention: High threat condition
Number of subjects: 134
Study 26995802 — intervention group
Group type: EXPERIMENTAL
Intervention: Low threat condition
Number of subjects: 134
Study 26995802 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 134
Study 24374724 — intervention group
Group type: EXPERIMENTAL
Intervention: Public social pressure
Number of subjects: 158
Study 24374724 — intervention group
Group type: COMPARATOR
Intervention: Anonymous setting
Number of subjects: 158
Study 24374724 — intervention group
Group type: COMPARATOR
Intervention: Trait prevalence feedback
Number of subjects: 158
Study 24374724 — intervention group
Group type: COMPARATOR
Intervention: Weight bias measure
Number of subjects: 158
Study 22922460 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Cortex Stimulation (MCS)
Number of subjects: 38
Study 20605536 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0
Study 18511531 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 units botulinum toxin type A (Dysport)
Number of subjects: 37
Study 18511531 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 37
Study 19092337 — intervention group
Group type: EXPERIMENTAL
Intervention: PPPD with gastric partition (PPPD-GP)
Number of subjects: 108
Study 19092337 — intervention group
Group type: COMPARATOR
Intervention: Conventional pancreatojejunostomy (PPPD-PJ)
Number of subjects: 108
Study 15570642 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level laser therapy
Number of subjects: 48
Study 15570642 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 48
Study 11320359 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin therapy
Number of subjects: 0
Study 9236502 — intervention group
Group type: EXPERIMENTAL
Intervention: Cow milk powder
Number of subjects: 25
Study 9236502 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 25
Study 8121246 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 0
Study 8121246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3307570 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol management (PM) group
Number of subjects: 48
Study 3307570 — intervention group
Group type: COMPARATOR
Intervention: Routine management (RM) group
Number of subjects: 48
Study 3307570 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol management (PM) group with initially high EVLW
Number of subjects: 48
Study 3307570 — intervention group
Group type: COMPARATOR
Intervention: Both groups with initial EVLW > 14 ml/kg
Number of subjects: 48
Study 31377713 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized post-extubation respiratory support (non-invasive ventilation or high-flow nasal cannula)
Number of subjects: 630
Study 31377713 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 630
Study 28173855 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for psychosocial distress
Number of subjects: 128
Study 28173855 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for psychosocial distress
Number of subjects: 128
Study 28173855 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated symptoms of psychosocial distress
Number of subjects: 128
Study 26085529 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based multimedia tutorial in addition to standard counseling (20-minute duration)
Number of subjects: 64
Study 26085529 — intervention group
Group type: COMPARATOR
Intervention: Standard preoperative counseling
Number of subjects: 64
Study 26085529 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based multimedia tutorial in addition to standard counseling
Number of subjects: 64
Study 24060199 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically driven monitoring (CDM)
Number of subjects: 0
Study 24060199 — intervention group
Group type: COMPARATOR
Intervention: Laboratory and clinical monitoring (LCM)
Number of subjects: 0
Study 21165641 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training intervention (six weeks, nine exercises progressed in difficulty)
Number of subjects: 26
Study 21165641 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (Foam vs. Hard, EO vs. EC)
Number of subjects: 26
Study 19745564 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil
Number of subjects: 29
Study 19745564 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelnidipine
Number of subjects: 29
Study 19745564 — intervention group
Group type: COMPARATOR
Intervention: Olmesartan medoxomil and Azelnidipine
Number of subjects: 29
Study 16940405 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir 75 mg (single oral dose)
Number of subjects: 12
Study 15251866 — intervention group
Group type: EXPERIMENTAL
Intervention: T2DM
Number of subjects: 45
Study 15251866 — intervention group
Group type: EXPERIMENTAL
Intervention: T2DM and Ob
Number of subjects: 45
Study 15251866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ob
Number of subjects: 45
Study 11502787 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy/estrogen replacement therapy (conjugated estrogens 0.625 mg daily + medroxyprogesterone acetate 2.5 mg daily)
Number of subjects: 489
Study 11502787 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (0.25 microg twice daily)
Number of subjects: 489
Study 11502787 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of hormone replacement therapy/estrogen replacement therapy + calcitriol
Number of subjects: 489
Study 11502787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 489
Study 11502787 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy/estrogen replacement therapy alone
Number of subjects: 489
Study 11502787 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol (in adherent women)
Number of subjects: 489
Study 11502787 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (in adherent women)
Number of subjects: 489
Study 9415505 — intervention group
Group type: EXPERIMENTAL
Intervention: Ignoring pain sensations
Number of subjects: 130
Study 9415505 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping self statements
Number of subjects: 130
Study 9415505 — intervention group
Group type: EXPERIMENTAL
Intervention: Catastrophizing
Number of subjects: 130
Study 9415505 — intervention group
Group type: EXPERIMENTAL
Intervention: Diverting attention
Number of subjects: 130
Study 9415505 — intervention group
Group type: EXPERIMENTAL
Intervention: Praying or hoping
Number of subjects: 130
Study 8484558 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 micrograms/kg of mivacurium preceded by 15 micrograms/kg of pancuronium
Number of subjects: 48
Study 8484558 — intervention group
Group type: EXPERIMENTAL
Intervention: 170 micrograms/kg of mivacurium preceded by 15 micrograms/kg of pancuronium
Number of subjects: 48
Study 8484558 — intervention group
Group type: COMPARATOR
Intervention: 200 micrograms/kg of mivacurium alone
Number of subjects: 48
Study 3322468 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (mean dose 73 mg each morning)
Number of subjects: 64
Study 3322468 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (mean dose 122 mg at night)
Number of subjects: 64
Study 29466533 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician intervention (workshop and up to 6 coaching calls)
Number of subjects: 312
Study 29466533 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician coaching sessions (dosage)
Number of subjects: 312
Study 29466533 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient intervention (3-session program)
Number of subjects: 312
Study 29466533 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between patient and clinician dosage
Number of subjects: 312
Study 29466533 — intervention group
Group type: COMPARATOR
Intervention: Control condition (patient and clinician in control)
Number of subjects: 312
Study 29466533 — intervention group
Group type: COMPARATOR
Intervention: Patient in intervention and clinician in control
Number of subjects: 312
Study 29466533 — intervention group
Group type: COMPARATOR
Intervention: Patient in control and clinician in intervention
Number of subjects: 312
Study 29466533 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient and clinician in intervention
Number of subjects: 312
Study 26827293 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus practice quitting program (N = 46)
Number of subjects: 93
Study 26827293 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (N = 47)
Number of subjects: 93
Study 26827293 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice quitting program (N = 46)
Number of subjects: 93
Study 23656209 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with 1 : 100,000 epinephrine
Number of subjects: 50
Study 23656209 — intervention group
Group type: COMPARATOR
Intervention: 4% articaine with 1 : 100,000 epinephrine bitartrate
Number of subjects: 50
Study 23656209 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 50
Study 22650122 — intervention group
Group type: EXPERIMENTAL
Intervention: Only-puncturing at Dazhong (KI 4) with respiratory reinforcing method
Number of subjects: 126
Study 22650122 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture therapy at Shenshu (BL 23)
Number of subjects: 126
Study 22650122 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Dazhong and routine acupuncture)
Number of subjects: 126
Study 19924132 — intervention group
Group type: EXPERIMENTAL
Intervention: N-PASS assessment tool during heelstick procedure
Number of subjects: 0
Study 19924132 — intervention group
Group type: COMPARATOR
Intervention: N-PASS assessment tool during sham heelstick procedure
Number of subjects: 0
Study 19924132 — intervention group
Group type: EXPERIMENTAL
Intervention: N-PASS assessment tool
Number of subjects: 0
Study 18399768 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodized oil administered orally
Number of subjects: 364
Study 16034225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ossur Rheo (variable-damping knee)
Number of subjects: 8
Study 16034225 — intervention group
Group type: EXPERIMENTAL
Intervention: Otto Bock C-leg (variable-damping knee)
Number of subjects: 8
Study 16034225 — intervention group
Group type: COMPARATOR
Intervention: Mauch SNS (mechanically passive knee)
Number of subjects: 8